Relationship register · Organisation
BS
Bristol-Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing and delivering innovative medicines that help patients overcome serious diseases.
Also known as BMS, Bristol-Myers Squibb Company
Relationship register 7 documented relationships
Documented relationships 7 documented relationships Christopher Boerner → Bristol-Myers Squibb · Employment Leigh MacConell, Ph.D. → Bristol-Myers Squibb · Employment Christopher Boerner → Bristol-Myers Squibb · Employment Corsee Sanders, Ph.D. → Bristol-Myers Squibb · Advisory role Bristol-Myers Squibb → Celgene · Ownership Christopher Boerner → Bristol-Myers Squibb · Employment Christopher Boerner, PhD → Bristol-Myers Squibb · Employment Bristol-Myers Squibb Bristol-Myers Squibb Christopher Boerner Christopher Boerner Leigh MacConell, Ph.D. Leigh MacConell, Ph.D. Corsee Sanders, Ph.D. Corsee Sanders, Ph.D. Celgene Celgene Christopher Boerner, PhD Christopher Boerner, PhD Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount. Detailed register Reported 3 Bristol Myers Squibb Announces Leadership Transition Plan theglobeandmail.com Position or object indicated by the source: “EVP, Chief Commercialization Officer”.
Reported 4 Alexander Casdin epirium.com Function or object indicated by the source: “development leadership roles”.
3 Bristol Myers Squibb Announces Leadership Transition Plan theglobeandmail.com 5 Bristol Myers Squibb Announces Leadership Transition Plan news.bms.com Function or object indicated by the source: “head of international markets”.
6 Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors finance.yahoo.com 7 Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors uk.finance.yahoo.com 8 PRN_FinancialWrapper markets.financialcontent.com Role or object identified by the source: “Transition Advisor”.
Amount not specified Reported 6 Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors finance.yahoo.com August 2018 3 Bristol Myers Squibb Announces Leadership Transition Plan theglobeandmail.com 5 Bristol Myers Squibb Announces Leadership Transition Plan news.bms.com Position or object indicated by the source: “EVP, Chief Commercialization Officer”.
November 1, 2023 Reported 3 Bristol Myers Squibb Announces Leadership Transition Plan theglobeandmail.com 5 Bristol Myers Squibb Announces Leadership Transition Plan news.bms.com Role or object indicated by the source: “CEO”.
Sources 1. 2. 3. 4. 5. 6. Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
Web page finance.yahoo.com
Translate the title
View original ↑ Back to text
7. Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
Web page uk.finance.yahoo.com
Translate the title
View original ↑ Back to text
8.